查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1768797

全球自动输血系统市场

Autotransfusion Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球自动输血系统市场规模将达到 4.677 亿美元

全球自动输血系统市场规模预计在2024年为3.665亿美元，到2030年将达到4.677亿美元，在2024-2030年的分析期间内，复合年增长率为4.1%。自体输血产品是本报告分析的细分市场之一，预计其复合年增长率为4.5%，到分析期结束时达到3.362亿美元。自动输血配件细分市场的复合年增长率预计在分析期间为3.3%。

美国市场规模估计为 1.002 亿美元，中国市场预计复合年增长率为 4.0%

美国自动输血系统市场规模预计2024年达到1.002亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到7,470万美元，在2024-2030年的分析期间内，复合年增长率为4.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为3.9%和3.5%。在欧洲，预计德国的复合年增长率为4.2%。

全球自动输血系统市场－主要趋势与驱动因素摘要

什么是自动输血系统？它如何改变手术中的血液管理？

自体输血系统是用于在手术中收集、过滤和回输患者自身血液的医疗设备，它改变了手术室和创伤环境中的血液管理方式。传统上，手术中需要血液的患者依赖捐赠者输血，但这有免疫反应、感染疾病和血型相容性有限等风险。自体血输血或细胞回收是收集患者在手术中流失的自身血液，过滤以清除杂质，然后重新註入患者体内。这个过程减少了对捐赠者血液的依赖，并将输血反应和血液传染感染疾病传播的风险降至最低。自体输血系统在涉及大量失血的手术（如心臟、整形外科和血管手术）以及创伤护理中特别有用。随着技术的进步，自体输血系统变得更加有效和紧凑，使其可用于更广泛的临床环境中，包括急诊室和战地医疗。透过利用患者自身的血液，这些系统提供了一种比传统输血更安全、更有效率、更具成本效益的替代方法，改善了患者的治疗效果，并为血液保护树立了新的标准。

自动输血系统在各个医疗领域是如何应用的？

自体输血系统功能多样，已广泛应用于各医学专科，各专科均利用该技术满足其独特的外科和重症监护需求。在失血量较高的心血管外科手术中，自体输血系统能够维持稳定的血液容积和血红素水平，从而减少对异体（捐赠者）输血的需求。这在诸如开胸手术和动脉瘤修復等复杂手术中尤其重要，因为即使少量的血液供应减少也可能造成严重后果。整形外科手术也是自体输血系统发挥重要作用的领域，尤其是在关节重建和脊椎手术中，这些手术可能会造成大量失血。自体输血可以最大限度地降低输血反应的风险，并透过避免使用异体血液製品来加速復原。在创伤和急诊护理中，快速反应至关重要，自体输血系统可以帮助临床医生在无法立即获得捐赠者血液的情况下稳定患者病情。在产科，自体输血系统可用于产后出血，降低大出血期间母婴的风险。自动输血系统的适应性使其在各种临床环境中具有价值，可提高病患安全性，改善治疗效果，并使医疗专业人员在手术和紧急情况下更好地控制血液管理。

在广泛采用自动输血系统的过程中，您面临哪些挑战？

儘管自体输血系统具有诸多优势，但在广泛应用之前仍需克服许多挑战。其中一个主要考虑因素是成本。自体输血设备的购买和维护成本高昂，这使得资源有限的小型诊所和医院难以取得。此外，这些系统需要训练有素的人员操作，并非所有医疗机构都拥有具备必要专业知识的人员，尤其是在农村和资源匮乏的地区。自体输血并非适用于所有类型的手术或患有某些疾病（例如感染疾病或恶性肿瘤）的患者，而且回收血液的再输血存在危险性。技术挑战还在于需要对血液进行精确过滤和处理以确保再输血的安全性，因为血液中残留的污染物可能会引起副作用。此外，自体输血的使用仍存在文化和患者自身的顾虑，某些患者不愿接受从体内抽取的自身血液，或表达个人信仰，这些都进一步阻碍了自体输血的接受。克服这些经济、临床和后勤挑战需要有针对性的培训计划、提高成本效益和易用性的技术进步，以及努力教育医疗专业人员和患者了解自体输血的安全性和有效性。

推动自体输血系统市场成长的关键因素有哪些？

自动输血系统市场在医疗技术进步、血液保护意识增强以及高失血量复杂手术日益普及的推动下实现了显着增长。技术创新推动了更紧凑、更有效率、更易于使用的自动输血系统的开发，这些系统可以应用于从大型医院到小型诊所的各种手术环境。这种多功能性扩展了自体输血在多个外科学科的应用可能性，包括心血管外科、整形外科和创伤外科。此外，对病人安全和减少输血相关併发症的日益关注，促使医疗保健提供者采取措施节约血液，减少对捐血的依赖。在全球血液供不应求和输血性行为感染疾病日益严重的背景下，自体输血提供了一种可靠的替代方案，可以减少对捐血的需求，这与医院提高安全性和准备度的目标一致。人口老化，尤其是在已开发国家，也使自体输血成为首选方案，因为接受手术的老年患者可能患有会增加异体输血风险的疾病。此外，法规和医疗保健指南越来越重视包括自体输血在内的血液管理策略，特别是在强调以患者为中心和具有成本效益的医疗保健的国家。技术进步、对更安全输血的需求不断增长、人口结构变化和支持性监管机构等多种因素共同推动自体输血市场的成长，并使其成为现代医疗保健中有价值的解决方案。

部分

产品类型（自体输血产品、自体输血配件）、应用（心血管外科、整形外科、妇产科、神经外科、其他应用）

受访公司范例

  • Atrium Medical Corporation（A Part of Getinge Group）
  • Becton, Dickinson and Company
  • Beijing ZKSK Technology Co., Ltd.
  • Braile Biomedica
  • Fresenius Medical Care AG & Co. KGaA
  • Gen World Medical Devices
  • Haemonetics Corporation
  • Livanova PLC
  • Medtronic PLC
  • Redax

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP21289

Global Autotransfusion Systems Market to Reach US$467.7 Million by 2030

The global market for Autotransfusion Systems estimated at US$366.5 Million in the year 2024, is expected to reach US$467.7 Million by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Autotransfusion Products, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$336.2 Million by the end of the analysis period. Growth in the Autotransfusion Accessories segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$100.2 Million While China is Forecast to Grow at 4.0% CAGR

The Autotransfusion Systems market in the U.S. is estimated at US$100.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$74.7 Million by the year 2030 trailing a CAGR of 4.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Autotransfusion Systems Market - Key Trends and Drivers Summarized

What Are Autotransfusion Systems, and How Are They Transforming Blood Management in Surgery?

Autotransfusion systems are medical devices designed to collect, filter, and return a patient’s own blood during surgery, transforming how blood is managed in operating rooms and trauma settings. Traditionally, patients requiring blood during surgery have relied on donor blood transfusions, which can introduce risks such as immune reactions, infections, and limited availability of compatible blood types. Autotransfusion, or cell salvage, allows for the collection of a patient’s own blood that is lost during surgery, filtering and cleaning it of impurities before reinfusing it back into the patient. This process reduces dependence on donor blood and minimizes the risk of transfusion reactions and transmission of bloodborne diseases. Autotransfusion systems are particularly valuable in surgeries involving significant blood loss, such as cardiac, orthopedic, and vascular procedures, as well as in trauma care. As technology advances, autotransfusion systems have become more effective and compact, making them accessible in a wider range of clinical settings, including emergency rooms and battlefield medicine. By utilizing the patient’s own blood, these systems provide a safer, more efficient, and cost-effective alternative to traditional transfusions, enhancing patient outcomes and setting new standards in blood conservation.

How Are Autotransfusion Systems Being Utilized Across Different Medical Specialties?

The versatility of autotransfusion systems has led to their adoption across various medical specialties, each leveraging this technology to meet unique surgical and emergency care needs. In cardiovascular surgery, where blood loss can be significant, autotransfusion systems help maintain stable blood volume and hemoglobin levels, reducing the need for allogeneic (donor) blood transfusions. This is especially important in complex procedures such as open-heart surgeries or aneurysm repairs, where even a small reduction in blood supply can have serious consequences. Orthopedic surgery is another area where autotransfusion systems play a vital role, particularly in joint replacements and spinal surgeries that may involve considerable blood loss. Autotransfusion minimizes the risk of transfusion reactions and supports faster recovery by avoiding foreign blood products. In trauma and emergency care, where rapid response is critical, autotransfusion systems allow clinicians to stabilize patients in situations where donor blood may not be immediately available. In obstetric care, autotransfusion systems can be used in cases of postpartum hemorrhage, reducing the risk to mother and child when blood loss is substantial. The adaptability of autotransfusion systems makes them invaluable in diverse clinical settings, where they enhance patient safety, improve outcomes, and offer healthcare providers greater control over blood management in surgeries and emergencies.

What Challenges Do Autotransfusion Systems Face in Widespread Adoption?

While autotransfusion systems offer numerous benefits, several challenges must be overcome to achieve broader adoption. One major consideration is cost, as autotransfusion equipment can be expensive to acquire and maintain, making it less accessible for smaller clinics and hospitals with limited resources. Additionally, the operation of these systems requires trained personnel, and not all healthcare settings have staff with the necessary expertise, particularly in rural or under-resourced areas. Clinical limitations are another factor; autotransfusion is not suitable for all types of surgeries or for patients with certain conditions, such as infections or malignancies, where reinfusing salvaged blood may pose a risk. Technical challenges also arise from the need for precision in filtering and processing blood to ensure it is safe for reinfusion, as any contaminants left in the blood could cause adverse reactions. Furthermore, some cultural and patient-specific concerns surround the use of autotransfusion, with certain patients expressing reluctance or personal beliefs against receiving their own blood if it has left the body, presenting an additional barrier to its acceptance. Overcoming these economic, clinical, and logistical challenges requires targeted training programs, technological advancements to improve cost efficiency and usability, and efforts to educate both medical professionals and patients on the safety and efficacy of autotransfusion.

What Major Factors Are Behind the Growth of the Autotransfusion System Market?

The autotransfusion system market is experiencing notable growth, driven by advancements in medical technology, rising awareness of blood conservation, and the increasing prevalence of complex surgeries with high blood loss. Technological innovations have led to the development of more compact, efficient, and user-friendly autotransfusion systems that can be integrated into a wider variety of surgical environments, from large hospitals to smaller clinics. This versatility has expanded the potential for autotransfusion across multiple surgical fields, including cardiovascular, orthopedic, and trauma surgery. Furthermore, the growing focus on patient safety and reducing transfusion-related complications has spurred healthcare providers to adopt methods that conserve blood and lower dependence on donor supplies. With shortages in the global blood supply and concerns about transfusion-transmissible infections, autotransfusion offers a reliable alternative that reduces demand for donor blood, aligning with hospitals’ goals to improve safety and preparedness. The increase in aging populations, especially in developed countries, is also a factor, as older patients undergoing surgery may have conditions that make allogeneic transfusions riskier, making autotransfusion a preferred choice. Additionally, regulatory and healthcare guidelines now emphasize blood management strategies that include autotransfusion, particularly in countries focused on patient-centered and cost-effective care. These intersecting factors-technological advances, rising demand for safer transfusions, demographic changes, and regulatory support-are propelling the growth of the autotransfusion market, cementing it as a valuable solution in modern healthcare.

SCOPE OF STUDY:

The report analyzes the Autotransfusion Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Autotransfusion Products, Autotransfusion Accessories); Application (Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Atrium Medical Corporation (A Part of Getinge Group)
  • Becton, Dickinson and Company
  • Beijing ZKSK Technology Co., Ltd.
  • Braile Biomedica
  • Fresenius Medical Care AG & Co. KGaA
  • Gen World Medical Devices
  • Haemonetics Corporation
  • Livanova PLC
  • Medtronic PLC
  • Redax

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Autotransfusion Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Blood Conservation Drives Growth in Autotransfusion Systems Market
    • Increasing Use of Autotransfusion in Cardiac and Orthopedic Surgeries Expands Market Applications
    • Here's How Advances in Autotransfusion Technology Improve Blood Recovery Efficiency
    • Growing Focus on Patient Safety Supports Adoption of Autotransfusion to Reduce Transfusion-Related Risks
    • Rising Incidence of Complex Surgeries Fuels Demand for Reliable Autotransfusion Systems
    • Increasing Emphasis on Minimally Invasive Procedures Drives Need for Compact Autotransfusion Devices
    • Here's How Autotransfusion Systems Enhance Blood Management in Trauma and Emergency Care
    • Advancements in Filtration Technology Improve Quality and Safety of Recycled Blood
    • Growing Adoption of Autotransfusion Systems in Military and Disaster Medicine Expands Market Scope
    • Here's How Increased Awareness of Blood-Borne Diseases Fuels Demand for Closed Autotransfusion Systems
    • Rising Demand for Blood Management Solutions in Developing Countries Supports Market Growth
    • Focus on Reducing Blood Supply Shortages Drives Adoption of Autotransfusion in Major Hospitals
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Autotransfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Autotransfusion Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Autotransfusion Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Autotransfusion Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Autotransfusion Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Orthopedic Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Orthopedic Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Autotransfusion Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cardiovascular Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Cardiovascular Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Obstetrics & Gynecological Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Obstetrics & Gynecological Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Neurological Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Neurological Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • CHINA
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 30: China Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: China 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 32: China Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Autotransfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: Europe 6-Year Perspective for Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Europe 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 40: France Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: France 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 42: France Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: France 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Germany 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Italy 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Italy 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 52: UK Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: UK 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 54: UK Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: UK 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Rest of World 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Rest of World 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030

IV. COMPETITION